Home/Filings/4/0001415889-21-003287
4//SEC Filing

FOLICK JEFFREY 4

Accession 0001415889-21-003287

CIK 0001671284other

Filed

Jun 29, 8:00 PM ET

Accepted

Jun 30, 9:25 PM ET

Size

32.9 KB

Accession

0001415889-21-003287

Insider Transaction Report

Form 4
Period: 2021-01-03
Transactions
  • Exercise/Conversion

    Common Stock

    2021-04-03$0.63/sh+11,382$7,1331,230,396 total
  • Conversion

    Common Stock

    2021-06-28+106,2711,348,052 total
  • Conversion

    Common Stock

    2021-06-28+96,2371,537,112 total
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2021-01-0311,385170,754 total
    Exercise: $0.63Exp: 2028-04-03Common Stock (11,385 underlying)
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2021-04-0311,382136,605 total
    Exercise: $0.63Exp: 2028-04-03Common Stock (11,382 underlying)
  • Conversion

    Common Stock

    2021-06-28+92,8231,440,875 total
  • Exercise/Conversion

    Common Stock

    2021-03-03$0.63/sh+22,767$14,2681,219,014 total
  • Exercise/Conversion

    Common Stock

    2021-05-03$0.63/sh+11,385$7,1351,241,781 total
  • Conversion

    Common Stock

    2021-06-28+39,9331,577,045 total
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2021-03-0322,767147,987 total
    Exercise: $0.63Exp: 2028-04-03Common Stock (22,767 underlying)
  • Conversion

    Series A Preferred Stock

    2021-06-28156,5700 total
    Common Stock (106,271 underlying)
  • Exercise/Conversion

    Common Stock

    2021-01-03$0.63/sh+11,385$7,1351,196,247 total
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2021-05-0311,385125,220 total
    Exercise: $0.63Exp: 2028-04-03Common Stock (11,385 underlying)
  • Conversion

    Series B Preferred Stock

    2021-06-2830,9410 total
    Common Stock (92,823 underlying)
  • Conversion

    Series C Preferred Stock

    2021-06-2832,0790 total
    Common Stock (96,237 underlying)
  • Conversion

    Series D Preferred Stock

    2021-06-2813,3110 total
    Common Stock (39,933 underlying)
Footnotes (4)
  • [F1]Reflects 1-for-3 forward stock split effected on June 2, 2021.
  • [F2]These stock options vest over four years as follows: (a) 25% vested on April 3, 2019 (one year after the grant date), and (b) 1/48 of the original grant amount (of 546,411) vests in monthly installments for the following three years.
  • [F3]Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date.
  • [F4]Each share of the Issuer's Preferred Stock Series, B, C and D converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date.

Issuer

Bright Health Group Inc.

CIK 0001671284

Entity typeother

Related Parties

1
  • filerCIK 0001213927

Filing Metadata

Form type
4
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 9:25 PM ET
Size
32.9 KB